Biotechnology
Company Overview of MedImmune Oncology Inc.
Company Overview
MedImmune Oncology Inc., a pharmaceutical company, engages in the development and commercialization of products for patients with cancer and acquired immune deficiency syndrome. MedImmune Oncology Inc. was formerly known as U.S. Bioscience, Inc. As a result of acquisition of U.S. Bioscience, Inc. by MedImmune, LLC, U.S. Bioscience, Inc. name was changed. The company was founded in 1987 and is based in West Conshohocken, Pennsylvania. As of November 23, 1999, MedImmune Oncology Inc. operates as a subsidiary of MedImmune, LLC.
100 Front Street
One Tower Bridge
Suite 400
West Conshohocken, PA 19428
United States
Founded in 1987
148 Employees
Phone:
610-832-0570
Key Executives for MedImmune Oncology Inc.
Similar Private Companies By Industry
| Company Name | Region |
| NeuroLogic, Inc. | United States |
| Vivelle Ventures LLC | United States |
| Sequel Pharmaceuticals, Inc. | United States |
| Healthcare Communications Group, Inc. | United States |
| Provasculon, Inc. | United States |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Greater Houston Partnership | United States |
Post a JobJobs
- Adelphi, MD | University of Maryland University CollegePosted: May 07
- Efland, NC | Orange County SchoolsPosted: May 19
- Rockville, MD | Lab Support, A Division of On AssignmentPosted: May 02
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
Sponsored Financial Commentaries
Sponsored Links
To contact MedImmune Oncology Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
